Assessing the stability of polio eradication after the withdrawal of oral polio vaccine. [PDF]
The oral polio vaccine (OPV) contains live-attenuated polioviruses that induce immunity by causing low virulence infections in vaccine recipients and their close contacts. Widespread immunization with OPV has reduced the annual global burden of paralytic
Michael Famulare +4 more
doaj +5 more sources
Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine [PDF]
Since 1992, surveillance for acute flaccid paralysis (AFP) cases was introduced in Malaysia along with the establishment of the National Poliovirus Laboratory at the Institute for Medical Research.
T. S. Saraswathy Subramaniam +4 more
doaj +2 more sources
Oral polio vaccine stockpile modeling: insights from recent experience
Background Achieving polio eradication requires ensuring the delivery of sufficient supplies of the right vaccines to the right places at the right times.
Kimberly M. Thompson +2 more
doaj +2 more sources
In March 2005, there was outbreak of Polio-1 and expanded throughout Java and Sumatera island. Oral monovalent polio vaccine type 1 (mOPV1) had succeeded in evereeming polio outbreak in Indonesia in 2005.
Edim Hartati +2 more
doaj +2 more sources
Through the use of trivalent oral poliovirus vaccine made from Sabin strains of types 1, 2, 3 (tOPV), outstanding success of Global polio eradication program has been achieved. Since 1999, wild polio virus type 2 does not circulate in the world.
Yu. H. Khapchaev +6 more
doaj +3 more sources
Safety and Immunogenicity of Trivalent Oral Polio Vaccine in Vaccinated Children and Vaccine-Naïve Infants: A Phase 4 Study. [PDF]
In the context of polio eradication, novel oral polio vaccines for type 2 (nOPV2) were developed, and types 1 and 3 polioviruses are being developed.
Mejía LR +4 more
europepmc +2 more sources
Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis. [PDF]
In September 2003 a WHO consultation group on vaccine-derived polioviruses (VDPV) concluded that in order to prevent future generations of paralytic polio after interruption of transmission of wild poliovirus, the use of trivalent oral polio vaccine (OPV)
D. L. HEYMANN +5 more
core +1 more source
Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings : a meta-analytic approach [PDF]
Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile for OCV reflects increasing priority
Merten, Sonja +19 more
core +1 more source
Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]
BACKGROUND: Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Khatib Ahmed M +27 more
core +1 more source
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio outbreak involving 305 cases occurred in Indonesia in 2006.
Long Chiau Ming +4 more
doaj +1 more source

